DMAA
Drugs Made In America Acquisition Corp. Ordinary SharesDMAA
DMAA
About: Drugs Made In America Acquisition Corp is a blank check company.
0
Funds holding %
of 7,433 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
400% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 2
33% more funds holding
Funds holding: 24 [Q1] → 32 (+8) [Q2]
33% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 6
24% more capital invested
Capital invested by funds: $171M [Q1] → $212M (+$41M) [Q2]
3.34% more ownership
Funds ownership: 58.79% [Q1] → 62.13% (+3.34%) [Q2]
50% less funds holding in top 10
Funds holding in top 10: 2 [Q1] → 1 (-1) [Q2]
Research analyst outlook
We haven’t received any recent analyst ratings for DMAA.
Financial journalist opinion
We haven’t received any recent news articles for DMAA.
Charts implemented using Lightweight Charts™